Always so well articulated Owl AE very much stressed the EMR prerequisites for Renalytix in my conversation with them, this makes it very much limited in its market demographic compared to PromarkerD.
In addition, I don't think the general population is quite ready for "AI based" predictive diagnosis just yet. PromarkerD has the upper edge here and with LON: RENX valued at A$350M, it's a good indicator of where PIQ could be in the near future.
Good bounce on PIQ today, no doubt the big buys that were queued up at 30c a couple of weeks ago would be eyeing an entry at these levels.
@Owl vs Fox You have a good memory! Stop loss caught me out back in 2018 when I tried to lock in gains. I won't be setting one again until this finds a 40c floor.
PIQ Price at posting:
28.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
AE very much stressed the EMR prerequisites for Renalytix in my conversation with them, this makes it very much limited in its market demographic compared to PromarkerD.
(20min delay)